About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Journal of Neurotrauma

Editor-in-Chief: John T. Povlishock, PhD

ISSN: 0897-7151 • 24 Issues Annually • Online ISSN: 1557-9042

Current Volume: 31

Latest Impact Factor* is 3.968

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

A dynamic new author services platform
to share, measure, and enhance the impact of your research
Complimentary one-year membership with submission to this journal

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Mary Ann Liebert, Inc. Submission Benefits Package

    Your submission to Journal of Neurotrauma provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:

    • Complimentary 12-month AuthorCite® membership
      Exclusively licensed by Mary Ann Liebert, Inc., AuthorCite® delivers a 360-degree view of your article from submission to publication to market impact. With an AuthorCite® membership, you’ll receive end-to-end manuscript submission tracking, a custom online microsite to promote you and your research, a professional suite of metrics and analytics to measure the impact of your article, 30-day OpenLink™ article sharing, and much more.
    • Rapid, rigorous peer-review and editorial attention
    • Immediate deposit to PubMed and other indexing services upon online publication
    • Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
    • Fast Track online-ahead-of-print publication
    • Global availability in over 170 countries
    • Open Access publication options

    Submitting Your Manuscript

    Submitting your manuscript to Journal of Neurotrauma delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. This includes a one-year membership to AuthorCite™, a robust author services platform for increasing the visibility of your research, and includes the ability to freely share your article for 30 days. Journal of Neurotrauma carries a manuscript processing charge* of $75.00 USD upon submission of each new manuscript.

    Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system.  Please note:  Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.

    Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.

    Click here to submit your paper via our fast and user-friendly electronic submission system.

    Manuscript Revisions

    Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at http://mc.manuscriptcentral.com/neurotrauma and click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code.

    Please be sure to follow the Instructions for Authors below on Manuscript Preparation.  Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge.  

    *The manuscript processing charge is independent of editorial decision and is non-refundable.

    Web-Based Electronic Manuscript Submission and Peer Review

    Journal of Neurotrauma is proud to announce the launch of its web-based manuscript submission and peer-review system called Manuscript Central.

    We invite all authors to submit online any new manuscripts that are to be considered for publication.

    As of January 20, 2006, only manuscripts submitted via the online system will be accepted for submission.  REVISIONS to papers originally submitted as hard copies must be submitted through the mail and not the online system.

    All new manuscripts must be submitted online.

    Please read the Instructions for Authors before submitting your paper online.

    For further information or questions about papers in the peer-review process, please contact  j.neurotrauma@verizon.net

    For technical information on using Manuscript Central, contact Patricia Meravy at (914) 740-2132 or PMeravy@liebertpub.com


    Instructions for Authors

    The Journal of Neurotrauma publishes papers dealing with all aspects of neurotrauma. This includes the anatomy, biochemistry, biophysics, immunology, pathology, pharmacology, and physiology of brain, spinal, and nerve injury. Papers published in this journal emphasize morphological, physiological, and biochemical studies of injured neurons and glial cells, mechanisms and treatments of acute and chronic injury of the nervous system, neural and glial regeneration, transplantation, in vivo and in vitro injury models, cellular growth factors, blood flow, and metabolism of injured nervous tissues, and recovery of function. Both laboratory and clinical studies are encouraged.

    The journal will consider original research papers, short communications, reviews, and letters to the editor. Case reports are not accepted by the Journal. All submissions, except letters, must be accompanied by an abstract of about 250 words and keywords (<5). Original research papers should have an Introduction, Materials and Methods, Results, and Discussion sections. Short communications should have no sections and 6 manuscript pages or less, two tables or two figures or one of each. Reviews are invited and will be considered.

    To help defray the cost of printing, the publisher requests that page charges of $45 per printed page be paid by all authors who have funds available from research grants and other sources. It should be noted that ability to pay page charges is not a prerequisite for publication in the Journal.


    Submissions to the journal will be reviewed by the editorial board. Every effort will be made to ensure a speedy review and a publication time of less than 6 months. Members of the editorial board will formulate a critique of the submitted manuscript. This critique will be sent to the author and, under special circumstances, may be published at the conclusion of the paper if the manuscript is accepted. A submitted manuscript (or any part of its essential substance) must not have been published or submitted for publication elsewhere before appearance in this journal (except abstracts in connection with scientific meetings). The journal is not responsible for lost manuscripts.


    Please read all the instructions to authors before submitting.




    Full mailing information should be included if not on title page, then the following page. Corresponding author should be identified on title page.  Prepare text double-spaced throughout.  Leave ample margins on sides, top and bottom of the page.  Please submit text in Microsoft Word.  On the first page, give the full title of the paper, full name(s) and institutional affiliation(s) of author(s) with the highest academic degrees and institutional titles. Provide a running title (<45 characters) and a Table of Contents title (<75 characters), if the full title is longer than these limits. We require the full mailing address and contact information (telephone, fax, and e-mail address) for EACH author listed on your article. Please include the address (es).  Please also indicate the corresponding author.  Supply an abstract (<250 words) which presents the reasons for the study, the main findings (with specific data), the principal conclusions, and a list of key words (maximum of 5).  Original research papers should contain the following sections: introduction, materials and methods, results, discussion, acknowledgments, references, tables, and figure legends. One subsection level is allowed. Short communications should be prepared similarly to original papers. Begin each section on a separate page.


    The Journal publishes all accepted papers within 72 hours of acceptance in their unedited, uncorrected format.  It is important to note that the information that is published online, and in all indexing services, is pulled directly from the data that is populated into the fields in Manuscript Central – NOT from the manuscript file – when the paper is originally uploaded to the system for peer review.  Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline, until the next revision of the article is published.  As such, it is critical that authors enter all authors’ names correctly into the system at the time of submission.

    The next revision will take place after the corresponding author sees page proofs, makes any necessary corrections, and returns the changes to the Publisher.  Once the alterations are completed, the revised version will be published on our website, and the newly corrected information will then be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.

    Please note that the typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.

    Journal of Neurotrauma is updating its referencing style to the numbered reference system.  All submitted manuscripts should be prepared according to this new style. Please see below for the revised instructions.
    New Reference Style

    Authors are responsible for the accuracy and completeness of their references. Number all references in the order they are cited in the text; do not alphabetize. In-text citations should be in numerical order, superscripted, not contained within parentheses or brackets, and placed after punctuation.  All references in text should be included in the reference list, and all references in the reference list should have a corresponding citation in the main text of the manuscript.

    Preparation of Reference Section:

    • Begin the Reference section on a separate page after the Author Disclosure Statement section
    • Double-space entire section
    • Personal communications, unpublished data, or manuscripts “in preparation” or “submitted for publication” should not be included in the Reference section. If necessary, these should be included at the appropriate place in the body of the text. Personal communications should include the contact’s first initial and last name, and the month and year of the communication.
    • List all authors and/or editors for each listed article.
    • Abbreviate journal titles in accordance with PubMed/Medline (www.ncbi.nlm.nih.gov/pubmed/)
    • For journal article titles, capitalize only the first letter of the title.
    • References to abstracts should be indicated as such, with the abstract number included, if applicable
    • For book citations, volume and edition numbers should be included when appropriate.

    Sample Styles:

    Lieutaud, T., Ndiaye, A., Laumon, B., and Chiron, M.  (2012). Spinal cord injuries sustained in road crashes are not on the decrease in France: a study based on epidemiological trends.  J. Neurotrauma 29, 479-487.

    Bele, S., and Brawanski, A. (2009). Biomarkers and surrogate markers,  in:  Neurotrauma and Critical Care of the Brain.   J. Jallo, and C.M. Loftus (eds).  Theime Publishing: New York, pps. 42-52.


    Type tables double-spaced in a separate file, number tables with Arabic numerals, and provide a legend for each table. Tabular data should not be duplicated in figures.

    The top of the illustration should be indicated. A legend should be supplied for each illustration, and all legends numbered consecutively and provided (double-spaced) in a separate file. Figures should be numbered in the order cited in the text. A complete set should be submitted the manuscript. Images should not show the name of the manufacturer. Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction. Photomicrographs should be cropped to 8cm width. Electron photomicrographs should have internal scale markers. If a figure consists of two or more parts, individual parts should have similar dimensions.

    Please follow these instructions carefully when preparing figure files for uploading:

    • Do not include any illustrations as part of your text file.
    • Do not prepare any figures in Word as they are not workable and will be rejected for production.
    • Line illustrations must be submitted at 900 DPI.
    • Halftones and color photos should be submitted at a minimum of 300 DPI.  (NB:  600 DPI images are more desirable for production).
    • PowerPoint files cannot be uploaded to Manuscript Central.
    • Save art as either TIFF or EPS files.  Do not submit JPEG files. (JPEG files are for screen representation-quality only and will print very poorly during the printing process.)  To ensure proper print quality, please submit only TIFF or EPS files.
    • Color art must be saved as CYMK not RGB.  (NB:  If RGB files are submitted, the files will be converted to CYMK and some color variation will occur).
    • Label figures and tables inside the files in addition to naming the file with the figure or table number.  (I.e., When figures or table files are opened, the figure or table number should appear inside the file.)
    • When naming your figure files, please label them with your last name, followed by a period (.), and then list the figure number.  Ex:  Smith.Fig 1.  Label figures and tables inside the files in addition to naming the file with the figure or table number.  (I.e., when figure or table files are opened, the figure or table number should appear inside the file.)

    Color illustrations can be printed in the journal with a subsidy from the author(s).  Please contact the Publisher for further details.


    Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper.  Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.

    Disclosure Statement
    Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."

    If no conflicts exist, the authors must state “No competing financial interests exist."


    Consult the “Style Manual for Biologic Journals,” 4th Edition, 1978 (American Institute of Biological Sciences, 1401 Wilson Blvd, Arlington, VA 22209.) Identify medications, materials, and devices by full nonproprietary name, brand name, and the manufacturer’s name, city, state, and country. Place this information in parentheses in the text.


    Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the journal for reproduction. If clearances are required by the author’s institution, statements concerning such clearance should be provided in the manuscript.


    Reports of research involving human and/or animal experimental subjects should be accompanied by a statement to the Editor, indicating approval by an Institutional Animal Care and Use Committee, Institutional Review Board or equivalent.


    Page proofs are sent to the corresponding author via e-mail, so please be sure to have any e-mail filters accept e-mail from the liebertpub.com domain. Please ensure that proper e-mail addresses are given.


    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.


    The statements and opinions expressed in JOURNAL OF NEUROTRAUMA are those of the individual contributors, editors, or advertisers; they do not necessarily represent the views of the other editors or the publisher. Unless specified otherwise, the authors and publisher disclaim any responsibility or liability for such material.


    The Journal is published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, Floor, New Rochelle, NY 10801-5215. Telephone (914) 740-2100, Fax (914) 740-2101, e-mail: info@liebertpub.com, www.liebertpub.com


  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Brain Connectivity

    Brain Connectivity

    Provides the latest translational research discoveries in brain mapping, modeling, novel research techniques, and more in the rapidly advancing field of connectivity research at the systems and network levels.

    Therapeutic Hypothermia
    and Temperature Management

    Therapeutic Hypothermia
    and Temperature Management

    Provides a strong multidisciplinary forum to ensure research advances are well disseminated and therapeutic hypothermia is used effectively to enhance patient outcomes from traumatic brain injury, cardiac arrest, and more.

Browse All Publications »